Mark Α. Zern

8.7k citations
127 papers · 7.1k indexed · h-index 48

Impact in

  • Hepatology top 0.2%
    • Liver physiology and pathology
    • Liver Disease and Transplantation
  • Pharmacology top 0.5%
    • Drug-Induced Hepatotoxicity and Protection

Papers in

Mark Α. Zern

127 papers receiving 7.0k citations

Peers

Mark Α. Zern
Comparison fields: 5 of 131
  • Hepatology 2.7k
  • Pharmacology 484
  • Epidemiology 1.8k
  • Cancer Research 662
  • Molecular Biology 2.8k
Replace Marcos Rojkind with:
Marcos Rojkind United States
Richard A. Rippe United States
Steven Dooley Germany
Samuele De Minicis Italy
Henning W. Zimmermann Germany
Grant A. Ramm Australia
Mario Chojkier United States
Achim Weber Switzerland
D. Montgomery Bissell United States
Konrad L. Streetz Germany
Mark Α. Zern relative to Marcos Rojkind United States Marcos Rojkind's profile →
Citations per field
00.5×1.5×
Marcos Rojkind · 1×
Citations per year

Countries citing papers authored by Mark Α. Zern

Since Specialization
Citations

This map shows the geographic impact of Mark Α. Zern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Α. Zern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Α. Zern more than expected).

Fields of papers citing papers by Mark Α. Zern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Α. Zern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Α. Zern. The network helps show where Mark Α. Zern may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Α. Zern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Α. Zern Line = papers co-authored together Mark Α. Zern links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201723
2 201513
3 201530
4 201218
5 201167
6 201156
7 201130
8 201028
9 200814
10 2006128
11 200448
12 2003134
13 200232
14 199944
15 199858
16 199869
17 199430
18
Extracellular matrix : chemistry, biology, and pathobiology with emphasis on the liver
199346
19 198975
20
Effect of chronic ethanol administration on hepatic protein synthesis and albumin mRNA in rats
19811

About Mark Α. Zern

Mark Α. Zern is a scholar working on Hepatology, Pharmacology, Molecular Biology, Surgery and Cancer Research, having authored 127 papers that have together received 7.1k indexed citations. Recurring topics across this work include Liver physiology and pathology (46 papers), Pluripotent Stem Cells Research (19 papers), Liver Disease Diagnosis and Treatment (19 papers), Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (12 papers), 3D Printing in Biomedical Research (12 papers), Drug-Induced Hepatotoxicity and Protection (11 papers) and Pancreatic function and diabetes (11 papers). The work is most often cited by research in Hepatology (2.7k citations), Pharmacology (484 citations), Epidemiology (1.8k citations), Cancer Research (662 citations) and Molecular Biology (2.8k citations). Mark Α. Zern has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Jian Wu, Francis R. Weiner, Mark J. Czaja, M A Giambrone, Luis Biempica, Yuyou Duan, M Eghbali, David A. Shafritz, Natalie J. Török and Kathleen C. Flanders. Their work appears in journals such as Hepatology, Gastroenterology, Stem Cells and Development, Journal of Biological Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026